Trial record 5 of 26 for: "Bacterial Conjunctivitis" | "Anti-Bacterial Agents"
Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01155999|
Recruitment Status : Completed
First Posted : July 2, 2010
Results First Posted : October 29, 2014
Last Update Posted : October 29, 2014
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Single (Investigator); Primary Purpose: Treatment|
Purulent Bacterial Conjunctivitis